BRCA1 and breast cancer: Given that the BRCA1 gene was identified over 20 years ago, that preventive mastectomy remains the gold standard, and that mutation carriers have strong preferences for chemoprevention, it is timely that an effective breast cancer risk reduction option be identified [9, 10].